期刊论文

中文

中国药物经济学

1673-5846

2024

19

02

76-78+82

10.12010/j.issn.1673-5846.2024.02.015

本校为第一机构

目的 探讨参芪养心汤联合沙库巴曲缬沙坦治疗老年慢性心力衰竭(CHF)的疗效及对患者血清趋化素、过氧化物酶体增殖物激活受体α(PPAR-α)水平的影响.方法 选取 2021 年 3 月至 2023 年 3 月湖南省中医药研究院附属医院收治的老年CHF患者82 例作为研究对象,随机分为对照组和观察组,每组41 例.对照组采用沙库巴曲缬沙坦治疗,观察组联合参芪养心汤治疗,比较两组的治疗效果.结果 观察组治疗有效率高于对照组,差异有统计学意义(P＜0.05);治疗后,观察组左室射血分数(LVEF)水平高于对照组,左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)水平低于对照组,差异有统计学意义(P＜0.05);治疗后,观察组血清...

Objective To explore the therapeutic effect of Shenqi Yangxin Tang combined with Shakubatra valisartan on elderly chronic heart failure(CHF)and its effect on serum chemokines and peroxisome proliferator-activated receptors-α(PPAR-α)in patients.Methods A total of 82 elderly CHF patients admitted to the Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine from March 2021 to March 2023 were selected as the study objects and randomly divided into control group and observation group,with 41 cases in each group.The control group was...